Stock Research: Baxter

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Baxter

NYSE:BAX US0718131099
56
  • Value
    45
  • Growth
    23
  • Safety
    Safety
    100
  • Combined
    60
  • Sentiment
    50
  • 360° View
    360° View
    56
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Baxter International Inc. is a global medtech company providing a portfolio of diagnostic, critical care, nutrition, hospital, and surgical products. It operates in the medical products and therapies, healthcare systems and technologies, and pharmaceuticals industries. In the last fiscal year, the company had a market cap of $14,497 million, profits of $4,046 million, revenue of $10,636 million, and 38000 employees.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 56 (better than 56% compared with alternatives), overall professional sentiment and financial characteristics for the stock Baxter are above average. The 360° View is based on consolidating four consolidated indicators, with half the metrics below and half above average for Baxter. The consolidated Value Rank has an attractive rank of 100, which means that the share price of Baxter is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means that the stock price is lower than for 100% of alternative stocks in the same industry. The consolidated Sentiment Rank has a good rank of 50, which means that professional investors are more optimistic about the stock than for 50% of alternative investment opportunities. But the consolidated Growth Rank has a low rank of 23, which means that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, invested capital growth, and stock returns. The consolidated Safety Rank has a riskier rank of 45, meaning the company has a riskier financing structure than 55 comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. ...read more

more
Index
Dividends USA
Energy Efficient
Diversity USA
Low Waste
Recycling
SDG 12
SDG 3
SDG 6
D.J. US Medical Equipment
S&P 500
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Oct-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
100 94 98 89
Growth
23 25 9 91
Safety
Safety
45 27 44 98
Sentiment
50 50 40 38
360° View
360° View
56 38 36 98
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
5 3 5 45
Opinions Change
50 50 31 23
Pro Holdings
n/a 66 67 30
Market Pulse
85 83 82 90
Sentiment
50 50 40 38
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
100 94 98 89
Growth
23 25 9 91
Safety Safety
45 27 44 98
Combined
60 30 51 100
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
72 55 64 50
Price vs. Earnings (P/E)
83 57 74 48
Price vs. Book (P/B)
73 52 41 44
Dividend Yield
96 90 96 94
Value
100 94 98 89
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
24 55 27 69
Profit Growth
61 39 19 60
Capital Growth
44 24 51 62
Stock Returns
13 37 39 79
Growth
23 25 9 91
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
19 18 13 46
Refinancing
65 43 69 97
Liquidity
61 61 60 84
Safety Safety
45 27 44 98

Similar Stocks

Discover high‑ranked alternatives to Baxter and broaden your portfolio horizons.

Meta

NasdaqGS:FB
Country: USA
Industry: Interactive Media & Services
Size: XX-Large
Full Stock Analysis

Intuit

NasdaqGS:INTU
Country: USA
Industry: Application Software
Size: X-Large
Full Stock Analysis

Lithia Motors

NYSE:LAD
Country: USA
Industry: Automotive Retail
Size: X-Large
Full Stock Analysis

Micron

NasdaqGS:MU
Country: USA
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.